Csl Stock Performance
| CSLLY Stock | USD 90.00 0.70 0.78% |
The firm shows a Beta (market volatility) of 0.38, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CSL's returns are expected to increase less than the market. However, during the bear market, the loss of holding CSL is expected to be smaller as well. At this point, CSL has a negative expected return of -0.21%. Please make sure to confirm CSL's standard deviation, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if CSL performance from the past will be repeated at future time.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days CSL has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Begin Period Cash Flow | 1.7 B | |
| Total Cashflows From Investing Activities | -1.6 B |
CSL |
CSL Relative Risk vs. Return Landscape
If you would invest 10,363 in CSL on August 27, 2024 and sell it today you would lose (1,363) from holding CSL or give up 13.15% of portfolio value over 90 days. CSL is currently producing negative expected returns and takes up 1.0483% volatility of returns over 90 trading days. Put another way, 9% of traded pink sheets are less volatile than CSL, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
CSL Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CSL's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as CSL, and traders can use it to determine the average amount a CSL's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2048
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CSLLY |
Estimated Market Risk
| 1.05 actual daily | 9 91% of assets are more volatile |
Expected Return
| -0.21 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.2 actual daily | 0 Most of other assets perform better |
Based on monthly moving average CSL is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CSL by adding CSL to a well-diversified portfolio.
CSL Fundamentals Growth
CSL Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of CSL, and CSL fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CSL Pink Sheet performance.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0613 | |||
| Profit Margin | 0.18 % | |||
| Operating Margin | 0.25 % | |||
| Current Valuation | 96.65 B | |||
| Shares Outstanding | 964.43 M | |||
| Price To Earning | 34.45 X | |||
| Price To Book | 6.77 X | |||
| Price To Sales | 9.04 X | |||
| Revenue | 10.49 B | |||
| EBITDA | 3.46 B | |||
| Cash And Equivalents | 10.44 B | |||
| Cash Per Share | 10.83 X | |||
| Total Debt | 3.86 B | |||
| Debt To Equity | 0.66 % | |||
| Book Value Per Share | 16.27 X | |||
| Cash Flow From Operations | 2.63 B | |||
| Earnings Per Share | 2.40 X | |||
| Total Asset | 28.35 B | |||
| Retained Earnings | 6.59 B | |||
| Current Asset | 3.82 B | |||
| Current Liabilities | 1.37 B | |||
About CSL Performance
Evaluating CSL's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if CSL has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CSL has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia. Csl operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 30000 people.Things to note about CSL performance evaluation
Checking the ongoing alerts about CSL for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for CSL help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CSL generated a negative expected return over the last 90 days |
- Analyzing CSL's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CSL's stock is overvalued or undervalued compared to its peers.
- Examining CSL's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CSL's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CSL's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CSL's pink sheet. These opinions can provide insight into CSL's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for CSL Pink Sheet Analysis
When running CSL's price analysis, check to measure CSL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSL is operating at the current time. Most of CSL's value examination focuses on studying past and present price action to predict the probability of CSL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSL's price. Additionally, you may evaluate how the addition of CSL to your portfolios can decrease your overall portfolio volatility.